Amboy Street Ventures

About The Fund

Amboy Street Ventures is the world's first venture capital fund specifically dedicated to fostering innovation in Women's Health & Sexual Wellbeing across all genders. Emphasizing a commitment to addressing a significant and underserved market, they target startups poised to disrupt the traditional landscape of the health industry, with a special focus on fertility, menopause, maternal health, LGBTQ+ health, menstruation, hormonal health, sexual health, and contraception. With an investment range between $100,000 and $5,000,000, and a sweet spot at $1,500,000, Amboy Street Ventures strategically finances early-stage companies at the Seed and Series A funding phases. They are keen on advancing healthcare solutions which promise to tap into the burgeoning $1 trillion women's health market by 2027. Their portfolio exemplifies a diverse spectrum of innovative enterprises including those focused on non-hormonal birth control, cutting-edge fertility assistance, digital healthcare services, and therapeutic developments. Companies like Evvy, Contraline, Alloy, and Bea Fertility are a few within their investment portfolio that exemplify the fund's mission to revolutionize healthcare offerings, particularly in the women's health and sexual wellness niche. Their involvement in the sector is buttressed by strategic news placements and active communication channels, fostering greater visibility for the fund and its mission. Amboy Street Ventures champions the marriage of sound investment strategy with purpose-driven funding to enhance quality of life and healthcare accessibility for women and beyond.